FDA
-
-
-
-
-
-
-
Contineum reports positive phase 1b data for chronic pain drug PIPE-791
-
-
-
-
-
-
-
Contineum Therapeutics (CTNM) Expands Clinical Development of PIPE-791
-
-
-
334,270 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


